# Efficacy Study of VA106483 in Males With Nocturia.

> **NCT01038843** · PHASE2 · COMPLETED · sponsor: **Vantia Ltd** · enrollment: 152 (actual)

## Conditions studied

- Nocturia

## Interventions

- **DRUG:** VA106483

## Key facts

- **NCT ID:** NCT01038843
- **Lead sponsor:** Vantia Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2010-07
- **Final completion:** 2010-08
- **Target enrollment:** 152 (ACTUAL)
- **Last updated:** 2014-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01038843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01038843, "Efficacy Study of VA106483 in Males With Nocturia.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01038843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*